We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




World's Smallest Medical Robot Travels the Bloodstream

By HospiMedica staff writers
Posted on 25 Jul 2007
The world's smallest robot, with a diameter of only one millimeter, can enter a patient's bloodstream and deliver medical treatment.

The tiny robot, developed by researchers of the mechanical engineering department at the Technion (Haifa, Israel) and of the Judea and Samaria College (Ariel, Israel), has the unique ability to "crawl” through the inner walls of blood vessels by using tiny arms that radiate from a central hub that allow it to withstand blood pressure in order to progress through veins and arteries. More...
The operators can manipulate the robot to move in increments, and the robots unique structure allows it to crawl within a variety of vessels with differing diameters.

The robot is powered by an external magnetic field, allowing it to be controlled for an unlimited amount of time during medical procedures. One possible application could be used for brachytherapy (short distance radiation therapy), which is commonly used to treat prostate cancer and cancers of the head and neck.

"This accomplishment of miniaturization is without precedent, as is the ability to control the robot's activity for unlimited periods of time, for any medical procedure,” said robot co-developer Oded Solomon, B.A., B.Sc., a researcher at the medical robotics lab of the Technion. "We hope this discovery can be used to improve the quality of care for diseases and many other conditions.”

"We have the option to use a few miniature robots for simultaneous intervention and controlled treatment in a number of cancer cells,” added Salomon, noting that smaller versions would increase the robots applicability.


Related Links:
Technion
Judea and Samaria College

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.